PubMed ·

Antithrombotic Therapy in Patients with Chronic Coronary Disease on Anticoagulation: Evidence from Contemporary Trials.

Sukhila Reddy, Lakshmi Kattamuri, Muhammad Asif and Debabrata Mukherjee

Published
Source
PubMed
Original
Read it at PubMed
Topics
Cardiology

In brief

Navigating Antithrombotic Therapy in Heart Patients

This paper reviews contemporary trials and guidelines to clarify the best long-term treatment strategies for patients with CCD on anticoagulation. It emphasizes the effectiveness of OAC monotherapy and provides guidance on when to consider adding antiplatelet therapy.

What they found: The review highlighted that OAC monotherapy is effective in preventing major cardiovascular events while significantly reducing the risk of bleeding. Trials showed that this approach is noninferior to combination therapies in terms of ischemic protection. The findings suggest that OAC should be the default therapy for most patients, with antiplatelet therapy reserved for specific high-risk cases.

AI-written summary, not medical advice. Check anything you rely on against the original paper.

From the abstract

Chronic coronary disease (CCD) commonly coexists with long-term oral anticoagulation (OAC), particularly for atrial fibrillation (AF). Combination antiplatelet therapy increases bleeding, whereas ischemic protection with OAC alone remains a concern.

The opening of the authors’ abstract. The rest is with PubMed.

Read the full abstract at PubMed

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Cardiology

Get the few papers worth your time in Cardiology every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics